HUTCHMED (China) Limited (HKG: 0013)
Hong Kong
· Delayed Price · Currency is HKD
23.20
-0.20 (-0.85%)
Jan 3, 2025, 2:04 PM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
2.42M HKD
Profits / Employee
-166.35K HKD
Market Cap
20.30B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
WuXi Biologics | 12,740 |
Sinopharm Group | 115,959 |
Innovent Biologics | 4,872 |
Sino Biopharmaceutical | 25,806 |
CSPC Pharmaceutical Group | 23,500 |
HUTCHMED (China) News
- 2 days ago - Chinese regulators accept NDA for Orpathys/Tagrisso combo - Seeking Alpha
- 2 days ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 2 days ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga
- 2 days ago - Hutchmed sells stake in unit - BusinessMirror
- 2 days ago - HUTCHMED divests $608 million in non-core assets - Seeking Alpha
- 2 days ago - HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy - GlobeNewsWire
- 3 days ago - Billionaire Li Ka-shing's Hutchmed in $608 mln health unit stake sales - Reuters
- 3 days ago - HUTCHMED to divest 45% stake in JV with Shanghai Pharma - Seeking Alpha